Escherichia coli producing ESBL are a major problem in the many different hospitals worldwide causing outbreaks as well as sporadic infections. A novel chromogenic agar medium (ChromID ESBL bioMèrieux, Marcy L’Etoile, France) was tested directly on a total of 162 clinical samples and plated in parallel on to common media including Mac Conkey agar (bioMèrieux, Marcy L’Etoile, France). Colonies presenting a different morphologic aspect and growing on media were identified and tested for susceptibility by VITEK 2 using GN-cards and AST-N013 cards (bioMérieux, Marcy L’Etoile, France) Confirmation of ESBL-producing isolates was performed by combinated double disk. We are not find errors.The chromID ESBL appears as an excellent medium for the screening and presumptive identification of ESBLproducing Enterobacteriaceae directly from clinical samples. Further studies with a wider range of clinical specimens are required to confirm this utility.
PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.